Suchergebnisse - "Li, Zhenyong"

PubPharm (9)

1

TFE3-SLC36A1 axis promotes resistance to glucose starvation in kidney cancer cells

enthalten in: The Journal of biological chemistry | 2024

von Lv, S. | Zhang, Z. | Li, Z. | +7

2

The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1

enthalten in: The Journal of biological chemistry | 2024

von Li, N. | Zhang, E. | Li, Z. | +9

3

Comparison of percutaneous balloon compression and microvascular decompression in the treatment of trigeminal neuralgia

enthalten in: Pakistan journal of medical sciences | 2023

von Li, Z. | Xie, Z. | Tang, G. | +1

4

Predictive value of monocyte to high-density lipoprotein cholesterol ratio and tumor markers in colorectal cancer and their relationship with clinicopathological characteristics

enthalten in: World journal of surgical oncology | 2023

von Zhang, X. | Qin, H. | Tan, X. | +4

5

Predictive value of monocyte to high-density lipoprotein cholesterol ratio and tumor markers in colorectal cancer and their relationship with clinicopathological characteristics

enthalten in: World journal of surgical oncology | 2023

von Zhang, X. | Qin, H. | Tan, X. | +4

6

OsPEX1, an extensin-like protein, negatively regulates root growth in a gibberellin-mediated manner in rice

enthalten in: Plant molecular biology | 2023

von Li, J. | Zhang, Y. | Li, Z. | +8

7

Phosphorus-containing fluorescence labeling material based on DCPO as well as preparation method and application of phosphorus-containing fluorescence labeling material

enthalten in: Europäisches Patentamt | 2022

von WANG LE | ZHANG XIAO | LI ZHENYONG | +2

8

Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention : A Prospective, Multi-Center, Intensive Monitoring Study

enthalten in: Frontiers in cardiovascular medicine | 2022

von Peng, X. | Li, Z. | Li, D. | +4

9

Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention : A Prospective, Multi-Center, Intensive Monitoring Study

enthalten in: Frontiers in cardiovascular medicine | 2021

von Li, P. | Zhang, H. | Luo, C. | +6

1
[1]